By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The New Glenn explosion has sparked market overreaction, with ASTS and PL experiencing unjustified drops. The real risk lies in potential launch capacity crunch and regulatory scrutiny, while opportunities exist in ASTS's SpaceX reliance and RKLB's Neutron positioning.
Risk: Potential launch capacity crunch and regulatory scrutiny
Opportunity: ASTS's SpaceX reliance and RKLB's Neutron positioning
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
- AST SpaceMobile (ASTS) stock dropped 17% to $111 after Blue Origin’s New Glenn rocket exploded during a hotfire test, though ASTS uses SpaceX Falcon 9 as its primary launch provider with a BlueBird 8-10 mission targeted for mid-June.
- Planet Labs (PL) stock fell 8% to $47.50 as commercial launch capacity tightening raised constellation refresh risk, while Rocket Lab (RKLB) stock slipped 6% to $139 though the company could eventually benefit from extended New Glenn grounding.
- Virgin Galactic (SPCE) stock rallied 11% to $5 as traders positioned for a customer shift from Blue Origin’s grounded New Shepard tourism program.
- Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and AST SpaceMobile didn't make the cut. Grab the names FREE today.
Space stocks are splitting sharply this Friday morning after Blue Origin's New Glenn rocket exploded during a hotfire test late Thursday at Cape Canaveral. AST SpaceMobile (NASDAQ:ASTS) stock is down 17% to $111, while Planet Labs (NYSE:PL) stock has dropped 8% to roughly $47.50 and Rocket Lab (NASDAQ:RKLB) stock has slipped 6% to $139.
Virgin Galactic (NYSE:SPCE) stock is the outlier, rallying 11% to $5. The suborbital tourism operator competes directly with Blue Origin's New Shepard program, and traders appear to be treating today's setback as a relative win for the SPCE story.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and AST SpaceMobile didn't make the cut. Grab the names FREE today.
All four names came into the session with serious cushions to give back. AST SpaceMobile stock was up 83% year to date (YTD), Planet Labs stock was up 161% YTD, Rocket Lab stock was up 112% YTD, and Virgin Galactic stock was up 41% YTD. That kind of run sets the stage for a violent unwind when a sector catalyst breaks the wrong way.
The catalyst itself is concrete. Blue Origin's New Glenn vehicle suffered an anomaly at Launch Complex 36 at Cape Canaveral Space Force Station around 9 p.m. Thursday during a hotfire test, where the engines ignite while the rocket is strapped to the pad. No injuries were reported.
The rocket was preparing for the Leo New Glenn 1 mission next week, carrying Amazon (NASDAQ:AMZN) Project Kuiper satellites. The blast also raises timeline questions for NASA's Artemis program, since the Blue Moon Mark 2 lunar lander was scheduled to launch on New Glenn next year.
Founder Jeff Bezos addressed the loss directly, stating, "Very rough day, but we'll rebuild whatever needs rebuilding and get back to flying. It's worth it." NASA Administrator Jared Isaacman visited Kennedy Space Center today, signaling that federal scrutiny will be heavy.
Four leading AI models discuss this article
"Launch provider concentration creates asymmetric volatility that the article understates for names like ASTS despite their non-Blue Origin exposure."
The article frames Blue Origin's New Glenn explosion as a direct negative for ASTS, PL, and RKLB while boosting SPCE, yet ASTS's 17% drop appears driven by sector-wide sentiment rather than its SpaceX Falcon 9 reliance. Planet Labs and Rocket Lab face genuine refresh and capacity risks from any extended grounding, but the 83-161% YTD gains across names suggest profit-taking amplified the moves. NASA's Artemis timeline scrutiny and concentrated launch dependencies create second-order volatility that could persist beyond one test failure, especially if insurance costs rise sector-wide.
ASTS's plunge could prove short-lived once investors confirm its mid-June SpaceX launch remains on track, with no direct exposure to New Glenn delays.
"Planet Labs faces genuine launch capacity risk that justifies part of today's selloff, but the 8% move underprices the duration of New Glenn's grounding if the investigation extends beyond 60 days."
The article conflates two separate risk categories and misses the real damage. ASTS down 17% despite zero exposure to New Glenn is panic-driven and likely recovers; the Falcon 9 launch in mid-June is the actual binary. PL's 8% drop is more justified—commercial launch scarcity genuinely threatens constellation refresh timelines, but PL's existing constellation generates revenue now. RKLB's 6% slip is noise; Electron's niche (small-lift) insulates it from New Glenn's heavy-lift market. SPCE's 11% rally is pure sentiment arbitrage with no fundamental basis; New Shepard's grounding doesn't redirect customers to suborbital tourism. The real risk: if New Glenn's investigation reveals systemic design flaws (not just a test anomaly), heavy-lift capacity stays constrained for 12+ months, which *does* pressure constellation operators' capex timing.
Blue Origin has a track record of recovering from failures (New Shepard, BE-4 issues), and a hotfire test anomaly is lower-risk than an orbital failure. The market may be overreacting, and ASTS could stabilize Monday if SpaceX Falcon 9 readiness is reconfirmed.
"The sell-off in ASTS is a mispricing caused by sector-wide panic, as their reliance on SpaceX makes them fundamentally insulated from Blue Origin's specific technical failure."
The market's reaction to the New Glenn failure is a textbook case of 'guilt by association' in the space sector. ASTS dropping 17% is irrational; they rely on SpaceX, not Blue Origin. This is a liquidity-driven flush, not a fundamental reassessment. However, the real risk is the broader 'launch capacity crunch.' If New Glenn is grounded for 6-12 months, the backlog for heavy-lift launch providers like SpaceX will tighten, driving up launch costs for everyone. While SPCE is rallying on a perceived tourism monopoly, they lack the capital efficiency of the others. I view this volatility as an entry point for high-conviction names like ASTS, provided the launch manifest remains intact.
The market may be pricing in a systemic 'space insurance' premium spike that will hit the margins of every satellite operator, regardless of their specific launch provider.
"The near-term news could catalyze a multi-quarter decline in revenue visibility across space names as cadence delays and backlog unwind, more than the headline price moves imply."
Even with a dramatic headline, the core drivers for ASTS, PL, RKLB aren’t resolved by one test mishap. New Glenn’s explosion may delay a few missions, but ASTS’ primary launch provider is SpaceX (Falcon 9) and a mid-June BlueBird mission remains in play; investors may be overreacting to the sector’s whiplash, pricing in a prolonged backlog unwind. SPCE’s bounce looks like sentiment, not a verified customer win, given the uncertain demand for suborbital tourism. The bigger risk is cadence and backlog: a few quarter delay in constellation refresh could trim revenue visibility for all four names longer than the day-trade move suggests.
Against my take: a major delay in NASA Artemis/Kuiper timelines or a sustained Blue Origin deficit could intensify comp, not relieve it; the sector could enter a slower growth regime.
"RKLB could benefit from New Glenn delays via Neutron if launch capacity tightens."
Claude downplays RKLB by calling the drop noise due to Electron insulation, yet ignores Neutron's positioning as a medium-lift alternative amid heavy-lift constraints. If New Glenn delays push operators toward diversified providers, RKLB gains from higher pricing power. This links the capacity crunch Gemini flagged to potential RKLB outperformance, beyond the short-term sentiment hit affecting ASTS and PL.
"Neutron's medium-lift upside is real, but Blue Origin's historical recovery speed means the grounding window is likely quarters, not years—enough to pressure PL capex timing but not enough to justify sector-wide repricing."
Grok's Neutron angle is sharp—medium-lift pricing power amid heavy-lift scarcity is real. But Claude's recovery-track-record point matters: Blue Origin fixed BE-4 issues and New Shepard anomalies without structural redesigns. A hotfire test failure ≠ orbital grounding. The market's 48-hour panic likely overstates duration risk. ASTS's 17% drop recovers if SpaceX Falcon 9 clears, but PL faces genuine constellation refresh delays if launch slots tighten for 2-3 quarters. That's the asymmetry nobody's fully priced.
"FAA regulatory tightening following high-profile failures will likely compress sector-wide valuation multiples regardless of individual launch provider reliability."
Claude, you’re missing the regulatory second-order effect. A high-profile failure in the 'New Space' era invites FAA scrutiny that transcends the specific vehicle. Even if New Glenn is a 'hotfire' anomaly, the FAA is currently under immense pressure to tighten launch licensing protocols for all commercial players. This isn't just about launch slots; it’s about a potential shift in the risk-aversion profile of the entire sector, which will compress valuation multiples across the board.
"Regulatory risk from FAA licensing delays could become the dominant, long-tail driver, delaying capex and cash flow for the sector."
Gemini's emphasis on FAA scrutiny is a necessary alarm, but it's more than a headline risk. If licensing delays extend into multiple quarters, the revenue visibility and capex pacing for ASTS, PL, RKLB could deteriorate even with solid backlog. Valuation won't just re-rate; it could shift cash-flow timing and credit covenants across the sector. Expect the regulatory drag to be the dominant, long-tail driver if Artemis/Kuiper timelines remain uncertain.
The New Glenn explosion has sparked market overreaction, with ASTS and PL experiencing unjustified drops. The real risk lies in potential launch capacity crunch and regulatory scrutiny, while opportunities exist in ASTS's SpaceX reliance and RKLB's Neutron positioning.
ASTS's SpaceX reliance and RKLB's Neutron positioning
Potential launch capacity crunch and regulatory scrutiny